Endothelial-derived SLIT2 protein and its receptor ROBO1 reportedly promote the migration and infiltration of cancer cells into endothelial tissue, whereas endothelial Slit2 knockout can inhibit tumor metastasis. Here, SLIT2 is linked to neoplasm.